Our Company
OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases.
Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics has 65+ employees and is listed on Euronext Paris.